Is pre-biopsy MRI cost-effective relative to usual care in the diagnosis of prostate cancer?
Principal Investigator
Name
Trisha Saini
Degrees
B.S., M.S.
Institution
Weill Cornell Medical College
Position Title
Student
Email
About this CDAS Project
Study
PLCO
(Learn more about this study)
Project ID
PLCO-466
Initial CDAS Request Approval
Apr 4, 2019
Title
Is pre-biopsy MRI cost-effective relative to usual care in the diagnosis of prostate cancer?
Summary
We are conducting a study to determine if pre-biopsy MRI is cost-effective relative to usual care (systematic biopsy) in the diagnosis of prostate cancer. The inputs from this data set will help us understand what the patient trajectory looks like over time using usual care compared to MRI to diagnose and treat prostate cancer.
Aims
This study aims to determine if MRI guided biospy is cost-effective compared to usual care.
Collaborators
Rachael Collins
Ludolph Guichard